Chemopreventive Effects of Pterostilbene in Metastatic Prostate Cancer Cells

作者: Phillip A. Zook

DOI:

关键词: OncologyProstate cancerPterostilbeneInternal medicineMedicineAnticarcinogenic AgentsProstate-specific antigen

摘要:

参考文章(36)
Grant Buchanan, Ryan A. Irvine, Gerhard A. Coetzee, Wayne D. Tilley, Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer and Metastasis Reviews. ,vol. 20, pp. 207- 223 ,(2001) , 10.1023/A:1015531326689
Colette M. Witkowski, Isaac Rabinovitz, Raymond B. Nagle, Kit-Sahn D. Affinito, Anne E. Cress, Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. Journal of Cancer Research and Clinical Oncology. ,vol. 119, pp. 637- 644 ,(1993) , 10.1007/BF01215981
Yan Dai, Duyen Ngo, Lora W. Forman, David C. Qin, Johanna Jacob, Douglas V. Faller, Sirtuin 1 Is Required for Antagonist-Induced Transcriptional Repression of Androgen-Responsive Genes by the Androgen Receptor Molecular Endocrinology. ,vol. 21, pp. 1807- 1821 ,(2007) , 10.1210/ME.2006-0467
D. A. Benitez, E. Pozo-Guisado, A. Alvarez-Barrientos, P. M. Fernandez-Salguero, E. A. Castellon, Mechanisms Involved in Resveratrol‐Induced Apoptosis and Cell Cycle Arrest in Prostate Cancer—Derived Cell Lines Journal of Andrology. ,vol. 28, pp. 282- 293 ,(2006) , 10.2164/JANDROL.106.000968
Shen Gao, Guo-Zhen Liu, Zhengxin Wang, Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. The Prostate. ,vol. 59, pp. 214- 225 ,(2004) , 10.1002/PROS.10375
Charles la Porte, Nha Voduc, Guijun Zhang, Isabelle Seguin, Danielle Tardiff, Neera Singhal, D. William Cameron, Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clinical Pharmacokinectics. ,vol. 49, pp. 449- 454 ,(2010) , 10.2165/11531820-000000000-00000
Chengfei Liu, Yezi Zhu, Wei Lou, Yuanyuan Cui, Christopher P. Evans, Allen C. Gao, Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells The Prostate. ,vol. 74, pp. 201- 209 ,(2014) , 10.1002/PROS.22741